Logo image of NWH-DB-G.CA

NORTHWEST HEALTHCARE PRO (NWH-DB-G.CA) Stock Fundamental Analysis

TSX:NWH-DB-G - Toronto Stock Exchange - CA667495AH84 - Currency: CAD

100.16  0 (0%)

Fundamental Rating

3

NWH-DB-G gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 43 industry peers in the Diversified REITs industry. There are concerns on the financial health of NWH-DB-G while its profitability can be described as average. NWH-DB-G is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year NWH-DB-G has reported negative net income.
NWH-DB-G had a positive operating cash flow in the past year.
In multiple years NWH-DB-G reported negative net income over the last 5 years.
NWH-DB-G had a positive operating cash flow in each of the past 5 years.
NWH-DB-G.CA Yearly Net Income VS EBIT VS OCF VS FCFNWH-DB-G.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

1.2 Ratios

NWH-DB-G has a worse Return On Assets (-7.77%) than 72.09% of its industry peers.
The Return On Equity of NWH-DB-G (-29.96%) is worse than 72.09% of its industry peers.
NWH-DB-G has a worse Return On Invested Capital (4.03%) than 67.44% of its industry peers.
NWH-DB-G had an Average Return On Invested Capital over the past 3 years of 2.72%. This is below the industry average of 5.49%.
The last Return On Invested Capital (4.03%) for NWH-DB-G is above the 3 year average (2.72%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -7.77%
ROE -29.96%
ROIC 4.03%
ROA(3y)0.78%
ROA(5y)1.54%
ROE(3y)1.12%
ROE(5y)4.48%
ROIC(3y)2.72%
ROIC(5y)2.85%
NWH-DB-G.CA Yearly ROA, ROE, ROICNWH-DB-G.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

With an excellent Operating Margin value of 63.56%, NWH-DB-G belongs to the best of the industry, outperforming 86.05% of the companies in the same industry.
NWH-DB-G's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 75.37%, NWH-DB-G belongs to the best of the industry, outperforming 81.40% of the companies in the same industry.
In the last couple of years the Gross Margin of NWH-DB-G has remained more or less at the same level.
Industry RankSector Rank
OM 63.56%
PM (TTM) N/A
GM 75.37%
OM growth 3Y-1.89%
OM growth 5Y-1.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.2%
NWH-DB-G.CA Yearly Profit, Operating, Gross MarginsNWH-DB-G.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100

More info and screens

2

2. Health

2.1 Basic Checks

NWH-DB-G has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for NWH-DB-G has been increased compared to 1 year ago.
The number of shares outstanding for NWH-DB-G has been increased compared to 5 years ago.
NWH-DB-G has a worse debt/assets ratio than last year.
NWH-DB-G.CA Yearly Shares OutstandingNWH-DB-G.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
NWH-DB-G.CA Yearly Total Debt VS Total AssetsNWH-DB-G.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

NWH-DB-G has an Altman-Z score of 3.27. This indicates that NWH-DB-G is financially healthy and has little risk of bankruptcy at the moment.
NWH-DB-G has a Altman-Z score of 3.27. This is amongst the best in the industry. NWH-DB-G outperforms 90.70% of its industry peers.
The Debt to FCF ratio of NWH-DB-G is 35.83, which is on the high side as it means it would take NWH-DB-G, 35.83 years of fcf income to pay off all of its debts.
NWH-DB-G's Debt to FCF ratio of 35.83 is on the low side compared to the rest of the industry. NWH-DB-G is outperformed by 83.72% of its industry peers.
NWH-DB-G has a Debt/Equity ratio of 1.75. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.75, NWH-DB-G is doing worse than 86.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.75
Debt/FCF 35.83
Altman-Z 3.27
ROIC/WACC0.55
WACC7.36%
NWH-DB-G.CA Yearly LT Debt VS Equity VS FCFNWH-DB-G.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.27 indicates that NWH-DB-G may have some problems paying its short term obligations.
The Current ratio of NWH-DB-G (0.27) is comparable to the rest of the industry.
A Quick Ratio of 0.27 indicates that NWH-DB-G may have some problems paying its short term obligations.
NWH-DB-G's Quick ratio of 0.27 is in line compared to the rest of the industry. NWH-DB-G outperforms 58.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
NWH-DB-G.CA Yearly Current Assets VS Current LiabilitesNWH-DB-G.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for NWH-DB-G have decreased strongly by -57.42% in the last year.
Looking at the last year, NWH-DB-G shows a very strong growth in Revenue. The Revenue has grown by 22.83%.
The Revenue has been growing slightly by 7.76% on average over the past years.
EPS 1Y (TTM)-57.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.49%
Revenue 1Y (TTM)22.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.76%
Sales Q2Q%-12.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.98%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.1%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NWH-DB-G.CA Yearly Revenue VS EstimatesNWH-DB-G.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NWH-DB-G.CA Yearly EPS VS EstimatesNWH-DB-G.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NWH-DB-G. In the last year negative earnings were reported.
NWH-DB-G is valuated quite expensively with a Price/Forward Earnings ratio of 107.79.
The rest of the industry has a similar Price/Forward Earnings ratio as NWH-DB-G.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.65, NWH-DB-G is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 107.79
NWH-DB-G.CA Price Earnings VS Forward Price EarningsNWH-DB-G.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NWH-DB-G is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, NWH-DB-G is valued expensively inside the industry as 90.70% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF 287.04
EV/EBITDA 70.38
NWH-DB-G.CA Per share dataNWH-DB-G.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NWH-DB-G does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

NWH-DB-G has a Yearly Dividend Yield of 10.04%, which is a nice return.
Compared to an average industry Dividend Yield of 8.03, NWH-DB-G pays a better dividend. On top of this NWH-DB-G pays more dividend than 93.02% of the companies listed in the same industry.
NWH-DB-G's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

The dividend of NWH-DB-G decreases each year by -3.23%.
NWH-DB-G is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)-3.23%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

NWH-DB-G has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-16.42%
EPS Next 2YN/A
EPS Next 3YN/A
NWH-DB-G.CA Yearly Income VS Free CF VS DividendNWH-DB-G.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

More info and screens

NORTHWEST HEALTHCARE PRO

TSX:NWH-DB-G (2/21/2025, 7:00:00 PM)

100.16

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-14 2024-11-14
Earnings (Next)03-05 2025-03-05/amc
Inst Owners22.5%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap24.82B
Analysts70
Price Target119.07 (18.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.61
Dividend Growth(5Y)-3.23%
DP-16.42%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.87%
PT rev (3m)-1.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 107.79
P/S 40.21
P/FCF 287.04
P/OCF 284.15
P/B 15.09
P/tB 15.97
EV/EBITDA 70.38
EPS(TTM)-2
EYN/A
EPS(NY)0.93
Fwd EY0.93%
FCF(TTM)0.35
FCFY0.35%
OCF(TTM)0.35
OCFY0.35%
SpS2.49
BVpS6.64
TBVpS6.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.77%
ROE -29.96%
ROCE 6.57%
ROIC 4.03%
ROICexc 4.07%
ROICexgc 4.15%
OM 63.56%
PM (TTM) N/A
GM 75.37%
FCFM 14.01%
ROA(3y)0.78%
ROA(5y)1.54%
ROE(3y)1.12%
ROE(5y)4.48%
ROIC(3y)2.72%
ROIC(5y)2.85%
ROICexc(3y)2.77%
ROICexc(5y)2.96%
ROICexgc(3y)2.82%
ROICexgc(5y)3.03%
ROCE(3y)4.43%
ROCE(5y)4.64%
ROICexcg growth 3Y-5.44%
ROICexcg growth 5Y-2.28%
ROICexc growth 3Y-5.29%
ROICexc growth 5Y-1.28%
OM growth 3Y-1.89%
OM growth 5Y-1.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.2%
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.75
Debt/FCF 35.83
Debt/EBITDA 7.28
Cap/Depr 25.64%
Cap/Sales 0.14%
Interest Coverage 1.88
Cash Conversion 22.07%
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z 3.27
F-Score5
WACC7.36%
ROIC/WACC0.55
Cap/Depr(3y)28.77%
Cap/Depr(5y)23.76%
Cap/Sales(3y)0.1%
Cap/Sales(5y)0.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.49%
EPS Next Y6.98%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.76%
Sales Q2Q%-12.43%
Revenue Next Year3.1%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.15%
EBIT growth 3Y8.67%
EBIT growth 5Y6.26%
EBIT Next Year10.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.25%
FCF growth 3Y-17.82%
FCF growth 5Y2.41%
OCF growth 1Y-55.96%
OCF growth 3Y-17.83%
OCF growth 5Y2.35%